November 18, 2026
Health news, explained with evidence
LIVE

Investigating Peptide Signaling to Improve Diabetic Wound Healing

🔬 Research 2 min read 👁 7

Researchers are studying how the naturally occurring molecules apelin and ELABELA may help accelerate wound repair in individuals with type 1 diabetes.

Investigating Peptide Signaling to Improve Diabetic Wound Healing🔬Research

Photo: Medical Xpress

Key points

  • Type 1 diabetes increases the risk of chronic wounds due to impaired blood flow and immune response.
  • Apelin and ELABELA are natural signaling molecules that help regulate blood vessel growth and tissue repair.
  • Experimental treatment with these peptides improved wound healing in diabetic mice models.
  • The research is in the early stages, and these molecules are not yet approved for human medical use.

Type 1 diabetes is known to complicate the body’s natural healing process, often leading to chronic wounds that are susceptible to infection and, in severe cases, potential amputation. Pedro Geralde of the Université de Sherbrooke recently presented findings at the American Physiological Society's 2026 Comparative Physiology conference regarding the role of two signaling molecules, apelin and ELABELA, in tissue repair.

High blood sugar levels associated with diabetes can impair immune function and restrict blood flow, creating a hostile environment for healing. The research team focused on how apelin and ELABELA, which are naturally produced in vascularized tissues, interact with the apelin receptor to regulate blood vessel growth and inflammation. In laboratory models, applying these molecules directly to wounds demonstrated an improved healing rate in diabetic mice compared to untreated subjects.

The study suggests that these peptides influence macrophages, which are essential immune cells for coordinating the inflammatory response and tissue regeneration. While these findings offer a new understanding of the biological pathways involved in diabetic wound complications, the researchers emphasize that these molecules are not yet available as treatments. Further clinical investigation is required to determine if this approach can be safely and effectively translated to human patients.

What to know: Apelin and ELABELA are currently being investigated as experimental therapeutic agents and are not found in over-the-counter products. Always consult with your healthcare provider regarding personal medical decisions or concerns about wound care.

Source Medical Xpress — medicalxpress.com/news/2026-11-qa-body-natural-wounds-diabetes.html ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.